Semax

Scientific Overview

Semax is a synthetic ACTH(4–10) analog studied primarily in neurobiology for effects on cognition-related pathways, neurotrophin expression, and neuroprotection models.

Mechanism focus

Reported to modulate BDNF/trkB transcription and monoaminergic systems in rodent CNS models; copper-binding properties have also been characterized.

Research Use Cases

• Neurotrophin gene-expression studies
• Cognitive and behavioral neuroscience models
• Ischemia/neuroprotection experimental systems
• Peptide–metal (copper) interaction chemistry

Use-Case Study Notations

• Case-study notation: hippocampal BDNF/trkB upregulation has been reported after Semax administration in rodent designs.
• Case-study notation: ischemia models have linked Semax/related glyprolines to neurotrophin pathway activation.
• Most Semax literature is preclinical or regional clinical research; interpret external validity cautiously.

Selected Studies

1. 01 Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampusPubMed 16996037
2. 02 Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterationsPubMed 33418449
3. 03 Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid FormationPubMed 35080861
4. 04 Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) bindingPubMed 27586814
5. 05 Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischaemiaPubMed 19633950

Related compounds

Selank